News
Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...
A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...
Pharmaceutical Technology on MSN8h
Trade-offs abound as big pharma makes direct-to-consumer transition
"Trade-offs abound as big pharma makes direct-to-consumer transition" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...
The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...
A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...
OpenSecrets on MSN8d
Pharma industry and Ballard Partners dominate the lobbying space in second quarter of 2025
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...
Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Pharma industry loses on Medicare price ...
The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...
The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...
Envirotainer invests in Swiss Airtainer to drive sustainable innovation in pharmaceutical cold chain
This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback